KalVista Pharmaceuticals News

KalVista Pharma Analyst Ratings

BenzingaApr 11 06:06 ET

Buy Rating on KalVista Pharmaceuticals Backed by Sebetralstat's Breakthrough in HAE Treatment

TipRanksMar 12 06:26 ET

KalVista Pharma Analyst Ratings

BenzingaMar 11 15:51 ET

Buy Rating Affirmed for KalVista Pharmaceuticals on Strong Phase 3 Results and Solid Financial Position

TipRanksMar 11 14:45 ET

Buy Rating Reinforced by Strategic CEO Appointment and Promising Drug Development at KalVista Pharmaceuticals

TipRanksMar 11 00:47 ET

Analysts' Top Healthcare Picks: KalVista Pharmaceuticals (KALV), Allakos (ALLK)

TipRanksFeb 26 16:10 ET

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and KalVista Pharmaceuticals (KALV)

TipRanksFeb 14 06:20 ET

KalVista Pharma Analyst Ratings

BenzingaFeb 13 14:16 ET

Buy Rating and Increased Price Target for KalVista Pharmaceuticals Following Sebetralstat's Clinical Triumphs

TipRanksFeb 13 14:15 ET

Leerink Partners Sticks to Its Buy Rating for KalVista Pharmaceuticals (KALV)

TipRanksFeb 7 08:41 ET

Optimism Intact for KalVista Pharmaceuticals Despite Delay in KONFIDENT Study Data: Outperform Rating Reaffirmed

TipRanksFeb 5 04:36 ET

Positive Outlook for KalVista Pharmaceuticals With Buy Rating Reiterated Ahead of Phase 3 Study Results

TipRanksDec 11, 2023 01:46 ET

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Cue Biopharma (CUE)

TipRanksNov 13, 2023 14:10 ET

Jefferies Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)

TipRanksSep 8, 2023 08:25 ET

HC Wainwright & Co. Reiterates Buy on KalVista Pharma, Maintains $16 Price Target

BenzingaSep 8, 2023 07:09 ET

KalVista Pharma Analyst Ratings

BenzingaSep 8, 2023 07:08 ET

Analysts Are Bullish on Top Healthcare Stocks: Bioxcel Therapeutics (BTAI), KalVista Pharmaceuticals (KALV)

TipRanksSep 8, 2023 06:30 ET

KalVista Pharma Analyst Ratings

BenzingaAug 22, 2023 09:51 ET

Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT), Integra Lifesciences (IART) and KalVista Pharmaceuticals (KALV)

TipRanksJul 12, 2023 04:40 ET

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and KalVista Pharmaceuticals (KALV)

TipRanksJul 10, 2023 06:30 ET